| Vial description: |
MRG135srj, MSG-related protein 1 |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 90% |
| Molecular weight: |
29, 5 kDa |
| Source: |
coli, E |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q99967 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Conjugation: |
histidine |
| Gene target: |
His-tag), CITED2 (1-270 |
| Short name: |
His-tag) Antibody, anti-CITED2 (1-270 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
His |
| Alternative name: |
2 (1-270, histidine-detection labelled) (Antibody to), including L-gutamic acid/L-aspartic acid-rich carboxy-terminal domain, antibody to-Cbp/p300-interacting transactivator |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
2, ASD8 and MRG-1 and MRG1 and P35SRJ and VSD2, CITED2 and IDBG-633814 and ENSBTAG00000011224 and 521378, CITED2 and IDBG-97161 and ENSG00000164442 and 10370, Cited2 and IDBG-134872 and ENSMUSG00000039910 and 17684, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007368 and determination of left/right symmetry and biological process this GO :0007417 and central nervous system development and biological process this GO :0007422 and peripheral nervous system development and biological process this GO :0007507 and heart development and biological process this GO :0007530 and sex determination and biological process this GO :0007569 and cell aging and biological process this GO :0008283 and cell proliferation and biological process this GO :0008584 and male this GO nad development and biological process this GO :0009612 and response to mechanical stimulus and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0010629 and negative regulation of gene expression and biological process this GO :0021602 and cranial nerve morphogenesis and biological process this GO :0022409 and positive regulation of cell-cell adhesion and biological process this GO :0030325 and adrenal gland development and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030851 and granulocyte differentiation and biological process this GO :0034405 and response to fluid shear stress and biological process this GO :0035035 and histone acetyltransferase binding and molecular function this GO :0035360 and positive regulation of peroxisome proliferator activated receptor signaling pathway and biological process this GO :0035802 and adrenal cortex formation and biological process this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043627 and response to estrogen and biological process this GO :0045787 and positive regulation of cell cycle and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046332 and SMAD binding and molecular function this GO :0046697 and decidualization and biological process this GO :0048536 and spleen development and biological process this GO :0048538 and thymus development and biological process this GO :0048596 and embryonic camera-type eye morphogenesis and biological process this GO :0048821 and erythrocyte development and biological process this GO :0050693 and LBD domain binding and molecular function this GO :0060136 and embryonic process involved in female pregnancy and biological process this GO :0060349 and bone morphogenesis and biological process this GO :0060411 and cardiac septum morphogenesis and biological process this GO :0060412 and ventricular septum morphogenesis and biological process this GO :0060971 and embryonic heart tube left/right pattern formation and biological process this GO :0061156 and pulmonary artery morphogenesis and biological process this GO :0061308 and cardiac neural crest cell development involved in heart development and biological process this GO :0061371 and determination of heart left/right asymmetry and biological process this GO :0061428 and negative regulation of transcription from RNA polymerase II promoter in response to hypoxia and biological process this GO :0070986 and left/right axis specification and biological process this GO :0071363 and cellular response to growth factor stimulus and biological process this GO :1900164 and nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry and biological process this GO :2000020 and positive regulation of male this GO nad development and biological process this GO :2001141 and regulation of RNA biosynthetic process and biological process, LBD domain binding, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000790 and nuclear chromatin and cellular component this GO :0001102 and RNA polymerase II activating transcription factor binding and molecular function this GO :0001105 and RNA polymerase II transcription coactivator activity and molecular function this GO :0001106 and RNA polymerase II transcription corepressor activity and molecular function this GO :0001568 and blood vessel development and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001829 and trophectodermal cell differentiation and biological process this GO :0001841 and neural tube formation and biological process this GO :0001843 and neural tube closure and biological process this GO :0001889 and liver development and biological process this GO :0001892 and embryonic placenta development and biological process this GO :0001944 and vasculature development and biological process this GO :0001947 and heart looping and biological process this GO :0002089 and lens morphogenesis in camera-type eye and biological process this GO :0002244 and hematopoietic progenitor cell differentiation and biological process this GO :0002521 and leukocyte differentiation and biological process this GO :0003151 and outflow tract morphogenesis and biological process this GO :0003156 and regulation of organ formation and biological process this GO :0003197 and endocardial cushion development and biological process this GO :0003281 and ventricular septum development and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0003714 and transcription corepressor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006351 and transcription, this GO :0001102 : RNA polymerase II activating transcription factor binding, this GO :0001102 : RNA polymerase II activating transcription factor binding and also this GO :0001105 : RNA polymerase II transcription coactivator activity and also this GO :0001106 : RNA polymerase II transcription corepressor activity and also this GO :0003682 : chromatin binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003713 : transcription coactivator activity and also this GO :0003714 : transcription corepressor activity and also this GO :0005515 : protein binding and also this GO :0035035 : histone acetyltransferase binding and also this GO :0046332 : SMAD binding and also this GO :0050693 : LBD domain binding, this GO :0001105 : RNA polymerase II transcription coactivator activity, this GO :0001106 : RNA polymerase II transcription corepressor activity, this GO :0003682 : chromatin binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003713 : transcription coactivator activity, this GO :0003714 : transcription corepressor activity, this GO :0005515 : protein binding, this GO :0035035 : histone acetyltransferase binding, this GO :0046332 : SMAD binding, this GO :0050693 : LBD domain binding, with Glu/Asp-rich carboxy-terminal domain, Cbp/p300-interacting transactivator |
| Identity: |
1987 |
| Gene: |
CITED2 |
More about : CITED2 |
| Long gene name: |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 |
| Synonyms gene name: |
2 , Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain |
| Synonyms: |
MRG1 |
| Locus: |
6q24, 1 |
| Discovery year: |
1999-06-11 |
| GenBank acession: |
U65093 |
| Entrez gene record: |
10370 |
| Pubmed identfication: |
8901575 10552932 |
| Havana BLAST/BLAT: |
OTTHUMG00000015691 |